Clinical Trial: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC35 Injection in Participants With Obesity or Overweight

U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07842640) titled 'A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC35 Injection in Participants With Obesity or Overweight' on Sept. 21.

Brief Summary: This randomized, double-blind, placebo-controlled single ascending dose (SAD)/ multiple ascending dose (MAD) study is designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of ASC35 injection

Study Start Date: Aug. 27

Study Type: INTERVENTIONAL

Condition: Chronic Weight Management

Intervention: DRUG: ASC35 Injection B, for subcutaneous use

ASC35 Injection B is an investigational once-monthly formulation of ASC35 administe...